Could NICE guidance on the choice of blood pressure lowering drugs be simplified?
نویسندگان
چکیده
Reecha Sofat specialist registrar in clinical pharmacology , Juan P Casas senior lecturer in epidemiology 2 , Anthony M Grosso honorary associate professor in clinical pharmacy 1 , Brian N C Prichard emeritus professor of clinical pharmacology , Liam Smeeth professor of clinical epidemiology , Raymond MacAllister professor of clinical pharmacology , Aroon D Hingorani professor of genetic epidemiology 1 2
منابع مشابه
Could we simplify NICE guidance on choosing anti-hypertensive drugs?
Stratification by age Current NICE recommendations represent an evolution of the view that blood pressure is best lowered with β blockers or ACE inhibitors in patients under 55 years (in whom an activated H igh blood pressure is the most common modifiable cause of cardiovascular morbidity and mortality worldwide, and blood pressure lowering drugs from four major classes (angiotensin converting ...
متن کاملManagement of type 2 diabetes in adults: summary of updated NICE guidance.
New evidence and developments regarding the management of blood glucose levels, antiplatelet therapy, and erectile dysfunction prompted this update of the 2009 guidance. There were safety concerns surrounding some blood glucose lowering medicines, new evidence on new dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, new indications and combinations...
متن کاملThe Role of Patients’ Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes
OBJECTIVES To assess whether patients' willingness to add a blood pressure-lowering drug and the importance they attach to specific treatment characteristics differ among age groups in patients with type 2 diabetes. MATERIALS AND METHODS Patients being prescribed at least an oral glucose-lowering and a blood pressure-lowering drug completed a questionnaire including a discrete choice experime...
متن کاملUse of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around The Globe
Background Evidence-informed deliberative processes (EDPs) were recently introduced to guide health technology assessment (HTA) agencies to improve their processes towards more legitimate decision-making. The EDP framework provides guidance that covers the HTA process, ie, contextual factors, installation of an appraisal committee, selecting health technologies and criteria, assessment, a...
متن کاملClinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
The European Society of Hypertension (ESH)/European Society of Cardiology (ESC) 2013 guidelines for the management of arterial hypertension included simplified blood pressure (BP) targets across patient groups, more balanced discussion on monotherapy vs. combination therapy, as well as reconfirmation of the importance of out-of-office BP measurements. In light of these updates, we wished to rev...
متن کامل